# Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

> **NCT01298700** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 806 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** bimatoprost 0.01% ophthalmic solution
- **DRUG:** bimatoprost 0.03% ophthalmic solution

## Key facts

- **NCT ID:** NCT01298700
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-31
- **Primary completion:** 2016-12-06
- **Final completion:** 2016-12-06
- **Target enrollment:** 806 (ACTUAL)
- **Last updated:** 2018-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298700, "Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01298700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*